Akt1, also known as protein kinase B? (PKB?), is the founding member of a protein kinase family composed of three members, Akt1, Akt2 and Akt3. Akt family members regulate a diverse array of cellular functions including apoptosis, cellular proliferation, differentiation and intermediary metabolism and they appear to play a very important role in human cancer. Using single Akt knockout mice, and mice lacking combinations of two or all three isoforms of Akt in T cells, we have shown that specific combinations of Akt isoforms regulate multiple steps in thymopoiesis and are required for the physiological function of fully differentiated mature T cells. In other studies, we have shown that mice with a combined ablation of Akt1 and Akt2, but not other combinations of Akt isoforms in T cells, lack detectable regulatory T cells in both the thymus and the spleen and develop a severe autoimmune syndrome. Finally, macrophages from Akt2, but not Akt1 or Akt3 knockout mice exhibit a defect in the induction of COX2 and TNF-? in response to LPS. The experiments in this proposal will utilize molecular biology, tissue culture and genetic strategies to address the role of different Akt isoforms in thymocyte differentiation and T cell function, with special emphasis on the regulatory T cells. These experiments will generate basic information regarding the function of the immune system. In addition, they are expected to generate information, which will allow us to make predictions regarding the potential toxicity of Akt inhibitors under development. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057436-13
Application #
7465565
Study Section
Special Emphasis Panel (ZRG1-MONC-U (01))
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1994-07-01
Project End
2012-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
13
Fiscal Year
2008
Total Cost
$356,011
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
079532263
City
Boston
State
MA
Country
United States
Zip Code
02111
Roper, Jatin; Sinnamon, Mark J; Coffee, Erin M et al. (2014) Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer. Cancer Lett 347:204-11
Sanidas, Ioannis; Polytarchou, Christos; Hatziapostolou, Maria et al. (2014) Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. Mol Cell 53:577-90
Ezell, Scott A; Polytarchou, Christos; Hatziapostolou, Maria et al. (2012) The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY. Proc Natl Acad Sci U S A 109:E613-21
Arranz, Alicia; Doxaki, Christina; Vergadi, Eleni et al. (2012) Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A 109:9517-22
Polytarchou, Christos; Iliopoulos, Dimitrios; Hatziapostolou, Maria et al. (2011) Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation. Cancer Res 71:4720-31
Hirsch, Heather A; Iliopoulos, Dimitrios; Joshi, Amita et al. (2010) A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 17:348-61
Iliopoulos, Dimitrios; Lindahl-Allen, Marianne; Polytarchou, Christos et al. (2010) Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 39:761-72
Androulidaki, Ariadne; Iliopoulos, Dimitrios; Arranz, Alicia et al. (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31:220-31
Iliopoulos, Dimitrios; Polytarchou, Christos; Hatziapostolou, Maria et al. (2009) MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2:ra62
Hirsch, Heather A; Iliopoulos, Dimitrios; Tsichlis, Philip N et al. (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69:7507-11

Showing the most recent 10 out of 31 publications